Total assets grew to $96.6B in 2026Q2 with PPE at $84.4B (87% of assets), while debt-to-equity rose to 0.37 from 0.25 in 2024Q3, indicating strategic re-leveraging to fund growth.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 11.32B | 7.66B | 7.41B | 7.17B | 7.06B | 5.94B | 3.42B | 3.46B | 3.02B | 4.9B | 4.34B | 4.06B | 3.49B | 2.22B | 1.91B | 2.78B | 2.17B | 1.89B | 3.39B | 2.18B | 2.24B | 2.05B | 1.2B | 855.34M | 774.32M | 523.72M | 611.88M | 296.59M | 193.5M | 184.42M | 151M |
| Cash & Short-Term Investments | 2.62B | 672.45M | 131M | 1.4B | 1.41B | 1.05B | 383.83M | 485.06M | 625M | 1.03B | 930M | 1.04B | 25M | 16M | 37M | 34M | 22M | 13M | 26.71M | 20.86M | 23.3M | 17.44M | 27.6M | 104.34M | 29.9M | 14.33M | 28.49M | 0 | 0 | 0 | 300K |
| Cash Only | 2.62B | 672.45M | 131M | 877M | 920M | 744M | 144.43M | 107.19M | 101M | 137M | 17M | 69M | 25M | 16M | 37M | 34M | 22M | 13M | 26.71M | 20.86M | 23.3M | 17.44M | 27.6M | 104.34M | 29.9M | 14.33M | 28.49M | 0 | 0 | 0 | 300K |
| Short-Term Investments | 0 | 0 | 0 | 525M | 491M | 309M | 239.4M | 377.87M | 524M | 893M | 913M | 974M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.28B | 4B | 4.13B | 3.19B | 3.56B | 3.11B | 1.96B | 1.91B | 1.15B | 2.72B | 2.29B | 1.95B | 2.12B | 1.43B | 1.2B | 2.08B | 1.48B | 1.15B | 1.51B | 1.66B | 1.95B | 1.55B | 1.05B | 751M | 744.41M | 509.39M | 550.39M | 250.29M | 143.96M | 168.69M | 150M |
| Days Sales Outstanding | 31.74 | 33.02 | 42.24 | 28.5 | 26.2 | 34.56 | 40.93 | 30.5 | 18.81 | 56.17 | 75.15 | 54.17 | 36.28 | 29.03 | 26.98 | 48.89 | 37.74 | 37.82 | 34.17 | 48.35 | 61.03 | 50.68 | 51.01 | 45.9 | 66.56 | 52.21 | 62.33 | 70.95 | 59.87 | 66.88 | 85.98 |
| Inventory | 2.79B | 2.62B | 2.79B | 2.03B | 1.81B | 1.55B | 832.03M | 888.37M | 955M | 894M | 689M | 525M | 665M | 632M | 554M | 550M | 477M | 584M | 0 | 479.69M | 163.09M | 487.27M | 0 | 0 | 0 | 0 | 34.49M | 46.3M | 49.54M | 15.73M | 0 |
| Days Inventory Outstanding | 29.64 | 27.49 | 56.39 | 25.55 | 19.91 | 25.36 | 17.43 | 29.54 | 20.42 | 22.17 | 21.8 | 14.31 | 15.35 | 16.31 | 15.63 | 26.03 | 16.16 | 50.69 | - | 34.03 | 12.84 | 41.16 | - | - | - | - | 12.11 | 67.13 | 54.84 | 27.88 | - |
| Other Current Assets | 636M | 370.7M | 355M | 542M | 276M | 35M | 245.68M | 175.82M | 116M | 79M | 283M | 375M | 510M | 0 | 0 | 0 | 63M | 146M | 1.85B | 498.56M | 106.01M | 488.43M | 117.59M | 0 | 0 | 0 | -1.5M | 0 | 0 | 0 | 700K |
| Total Non-Current Assets | 85.26B | 84.1B | 77.95B | 68.79B | 69.08B | 70.72B | 55.66B | 58.83B | 68.54B | 68.97B | 54.31B | 55.22B | 56.71B | 49.54B | 47.07B | 44.5B | 40.5B | 39.13B | 39.26B | 33.93B | 30.92B | 19.8B | 17.17B | 13.34B | 12.58B | 8.52B | 7.16B | 4.55B | 3.05B | 2.75B | 1.91B |
| Property, Plant & Equipment | 84.45B | 80.58B | 77.33B | 68.25B | 68.53B | 70.16B | 52.9B | 53.85B | 67.2B | 67.8B | 53.29B | 54.06B | 56.04B | 49.1B | 46.64B | 44.11B | 40.47B | 39.12B | 38.97B | 33.9B | 30.77B | 19.69B | 17.06B | 13.27B | 12.5B | 8.44B | 7.14B | 4.55B | 3.03B | 2.75B | 1.91B |
| Fixed Asset Turnover | 0.64x | 0.55x | 0.46x | 0.60x | 0.72x | 0.47x | 0.33x | 0.42x | 0.33x | 0.26x | 0.21x | 0.24x | 0.38x | 0.37x | 0.35x | 0.35x | 0.35x | 0.28x | 0.42x | 0.37x | 0.38x | 0.57x | 0.44x | 0.45x | 0.33x | 0.42x | 0.45x | 0.28x | 0.29x | 0.34x | 0.33x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 102.83M | 217.47M | 287M | 292M | 0 | 0 | 0 | 306M | 310M | 321M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 809M | 3.52B | 620M | 541M | 553M | 565M | 2.66B | 2.71B | 1.06B | 876M | 1.02B | 1.16B | 674M | 136M | 117M | 70M | 25M | 18M | 292.62M | 30.79M | 154.94M | 106.99M | 107.99M | 73.43M | 83.41M | 74.82M | 22.5M | 1.45M | 20.12M | 0 | 0 |
| Total Assets | 96.58B | 91.76B | 85.36B | 75.95B | 76.14B | 76.67B | 59.09B | 62.29B | 71.56B | 73.87B | 58.65B | 59.27B | 60.2B | 51.75B | 48.98B | 47.28B | 42.67B | 41.02B | 42.65B | 36.11B | 33.16B | 21.85B | 18.41B | 14.64B | 13.36B | 9.04B | 7.78B | 4.85B | 3.25B | 2.93B | 2.06B |
| Asset Turnover | 0.57x | 0.48x | 0.42x | 0.54x | 0.65x | 0.43x | 0.30x | 0.37x | 0.31x | 0.24x | 0.19x | 0.22x | 0.35x | 0.35x | 0.33x | 0.33x | 0.34x | 0.27x | 0.38x | 0.35x | 0.35x | 0.51x | 0.41x | 0.41x | 0.31x | 0.39x | 0.41x | 0.27x | 0.27x | 0.31x | 0.31x |
| Asset Growth % | 14.48% | 7.49% | 12.38% | -0.25% | -0.68% | 29.75% | -5.14% | -12.95% | -3.12% | 25.95% | -1.06% | -1.54% | 16.32% | 5.66% | 3.6% | 10.8% | 4.01% | -3.81% | 18.1% | 8.91% | 51.75% | 18.7% | 25.73% | 9.61% | 47.74% | 16.28% | 60.3% | 49.37% | 10.82% | 42.09% | 129.08% |
| Total Current Liabilities | 11.32B | 8.06B | 9.63B | 7.43B | 8.65B | 7.42B | 3.99B | 5.12B | 4.76B | 6.26B | 5.09B | 4.59B | 5.14B | 5.23B | 3.98B | 4.03B | 3.71B | 2.4B | 3.42B | 3.56B | 3.07B | 3.82B | 1.89B | 1.36B | 788.48M | 530.09M | 688.36M | 260.42M | 136.22M | 204.43M | 152M |
| Accounts Payable | 1.56B | 1.1B | 1.08B | 1.42B | 1.34B | 803M | 523.55M | 629.27M | 779M | 775M | 595M | 571M | 564M | 637M | 465M | 526M | 274M | 240M | 382.47M | 379.38M | 842.26M | 573.32M | 379.17M | 463.74M | 336.8M | 249.92M | 673.37M | 260.42M | 136.22M | 204.43M | 152M |
| Days Payables Outstanding | 14.79 | 11.59 | 21.79 | 17.81 | 14.71 | 13.16 | 10.97 | 20.93 | 16.66 | 19.22 | 18.83 | 15.56 | 13.02 | 16.44 | 13.12 | 24.89 | 9.28 | 20.83 | 21.8 | 26.91 | 66.31 | 48.42 | 52 | 72.24 | 80.11 | 120.39 | 236.49 | 377.59 | 150.8 | 362.47 | 427.1 |
| Short-Term Debt | 2.21B | 813.34M | 2.4B | 980M | 404M | 1B | 1.2B | 2.02B | 1.14B | 1.88B | 1.81B | 1.73B | 980M | 1.44B | 798M | 359M | 397M | 643M | 420.11M | 0 | 0 | 0 | 194.38M | 184.21M | 23.61M | 15.92M | 16.5M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.76B | 5.23B | 909M | 1.5B | 1.13B | 2.04B | 2.17B | 2.29B | 394M | 1.01B | 463M | 206M | 319M | 418M | 155M | 455M | 870M | 0 | 815.93M | 1.62B | 610.44M | 1.47B | 297.58M | 0 | 0 | 0 | -1.5M | 0 | 0 | 0 | 0 |
| Current Ratio | 1.00x | 0.95x | 0.77x | 0.96x | 0.82x | 0.80x | 0.86x | 0.68x | 0.63x | 0.78x | 0.85x | 0.88x | 0.68x | 0.42x | 0.48x | 0.69x | 0.59x | 0.79x | 0.99x | 0.61x | 0.73x | 0.54x | 0.63x | 0.63x | 0.98x | 0.99x | 0.89x | 1.14x | 1.42x | 0.90x | 0.99x |
| Quick Ratio | 0.75x | 0.63x | 0.48x | 0.69x | 0.61x | 0.59x | 0.65x | 0.50x | 0.43x | 0.64x | 0.72x | 0.77x | 0.55x | 0.30x | 0.34x | 0.55x | 0.46x | 0.54x | 0.99x | 0.48x | 0.68x | 0.41x | 0.63x | 0.63x | 0.98x | 0.99x | 0.84x | 0.96x | 1.06x | 0.83x | 0.99x |
| Cash Conversion Cycle | 46.59 | 48.92 | 76.84 | 36.24 | 31.4 | 46.77 | 47.4 | 39.11 | 22.57 | 59.12 | 78.13 | 52.91 | 38.61 | 28.9 | 29.49 | 50.02 | 44.62 | 67.68 | - | 55.46 | 7.56 | 43.41 | - | - | - | - | -162.04 | -239.51 | -36.09 | -267.7 | - |
| Total Non-Current Liabilities | 38.47B | 39.37B | 36.26B | 28.69B | 29.32B | 32.3B | 29.68B | 30.19B | 34.82B | 35.95B | 27.29B | 27.3B | 26.17B | 20.75B | 20.72B | 20.35B | 18.53B | 19.19B | 20.86B | 19.23B | 19.4B | 9.79B | 9.2B | 6.72B | 7.7B | 4.64B | 3.87B | 2.7B | 1.83B | 1.52B | 836.9M |
| Long-Term Debt | 14.93B | 16.16B | 16.42B | 9.82B | 11.04B | 13.69B | 15.78B | 14.34B | 19.48B | 20.58B | 14.99B | 15.06B | 13.02B | 8.22B | 7.94B | 8.21B | 8.5B | 9.66B | 12.6B | 10.94B | 11.04B | 3.32B | 3.54B | 2.64B | 4.07B | 2.67B | 2.46B | 2.16B | 1.43B | 1.14B | 588.2M |
| Capital Lease Obligations | 4.67B | 2.73B | 1.21B | 0 | 1.3B | 1.4B | 1.18B | 1.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 40.62B | 11.28B | 10.54B | 10.18B | 10.11B | 10.22B | 7.96B | 10.17B | 11.45B | 10.97B | 9.07B | 9.34B | 8.97B | 8.18B | 8.17B | 8.22B | 7.9B | 7.69B | 7.14B | 6.73B | 6.96B | 5.04B | 4.45B | 3.59B | 3.19B | 1.78B | 1.24B | 504.92M | 374.61M | 318.8M | 224.3M |
| Other Non-Current Liabilities | 12.17B | 9.2B | 8.09B | 8.69B | 6.87B | 6.99B | 4.76B | 4.46B | 3.89B | 4.4B | 3.22B | 2.89B | 4.17B | 4.35B | 4.61B | 3.91B | 2.13B | 1.85B | 1.12B | 1.56B | 1.39B | 1.43B | 1.21B | 488.21M | 440.67M | 194.21M | 172.47M | 36.17M | 34.06M | 67.19M | 24.4M |
| Total Liabilities | 49.79B | 47.43B | 45.89B | 36.12B | 37.97B | 39.72B | 33.67B | 35.31B | 39.59B | 42.21B | 32.38B | 31.89B | 31.31B | 25.98B | 24.7B | 24.38B | 21.68B | 21.6B | 24.28B | 22.79B | 22.47B | 13.62B | 11.09B | 8.08B | 8.49B | 5.17B | 4.56B | 2.96B | 1.97B | 1.73B | 988.4M |
| Total Debt | 17.14B | 19.71B | 20.28B | 10.8B | 12.98B | 16.28B | 18.17B | 17.58B | 20.62B | 22.46B | 16.8B | 16.79B | 14B | 9.66B | 8.74B | 8.57B | 9.22B | 10.3B | 13.02B | 10.94B | 11.04B | 3.32B | 3.73B | 2.83B | 4.1B | 2.69B | 2.47B | 2.16B | 1.43B | 1.14B | 588.2M |
| Net Debt | 14.53B | 19.03B | 20.15B | 9.92B | 12.06B | 15.53B | 18.02B | 17.47B | 20.52B | 22.32B | 16.79B | 16.73B | 13.98B | 9.64B | 8.7B | 8.54B | 9.2B | 10.29B | 12.99B | 10.92B | 11.02B | 3.3B | 3.71B | 2.72B | 4.07B | 2.67B | 2.44B | 2.16B | 1.43B | 1.14B | 587.9M |
| Debt / Equity | 0.37x | 0.44x | 0.51x | 0.27x | 0.34x | 0.44x | 0.71x | 0.65x | 0.64x | 0.71x | 0.64x | 0.61x | 0.48x | 0.37x | 0.36x | 0.37x | 0.45x | 0.53x | 0.71x | 0.82x | 1.03x | 0.40x | 0.51x | 0.46x | 0.84x | 0.69x | 0.77x | 1.14x | 1.12x | 0.94x | 0.55x |
| Debt / EBITDA | 0.69x | 1.24x | 0.87x | 0.64x | 0.59x | 1.07x | 3.03x | 1.03x | 2.02x | 2.99x | 4.52x | 3.54x | 1.44x | 1.21x | 1.18x | 1.08x | 1.29x | 1.95x | 1.39x | 2.10x | 1.72x | 0.59x | 0.86x | 0.87x | 1.69x | 1.27x | 1.17x | 2.60x | 2.69x | 2.06x | 1.18x |
| Net Debt / EBITDA | 0.58x | 1.20x | 0.86x | 0.59x | 0.55x | 1.02x | 3.00x | 1.02x | 2.01x | 2.97x | 4.51x | 3.53x | 1.44x | 1.20x | 1.18x | 1.08x | 1.29x | 1.94x | 1.38x | 2.10x | 1.71x | 0.58x | 0.85x | 0.84x | 1.68x | 1.26x | 1.16x | 2.60x | 2.69x | 2.06x | 1.18x |
| Interest Coverage | 17.72x | 13.74x | 14.44x | 15.71x | 21.45x | 14.34x | -0.05x | 6.08x | 5.41x | 4.95x | -1.48x | -0.78x | 17.03x | 11.89x | 8.13x | 11.00x | 7.39x | 5.82x | 57.80x | 8.72x | 26.67x | 25.04x | 13.59x | 17.30x | 11.17x | 13.14x | 12.15x | - | 4.22x | - | 11.87x |
| Total Equity | 46.8B | 44.33B | 39.47B | 39.83B | 38.17B | 36.95B | 25.42B | 26.98B | 31.97B | 31.65B | 26.27B | 27.38B | 28.89B | 25.77B | 24.28B | 22.9B | 20.37B | 19.43B | 18.37B | 13.32B | 10.69B | 8.24B | 7.32B | 6.11B | 4.87B | 3.87B | 3.22B | 1.89B | 1.28B | 1.2B | 1.07B |
| Equity Growth % | 6.39% | 12.32% | -0.91% | 4.34% | 3.33% | 45.36% | -5.81% | -15.61% | 1.01% | 20.5% | -4.07% | -5.23% | 12.1% | 6.13% | 6.05% | 12.42% | 4.85% | 5.72% | 37.93% | 24.62% | 29.78% | 12.46% | 19.9% | 25.49% | 25.84% | 20.25% | 69.99% | 48.18% | 6.1% | 12.08% | 116.4% |
| Book Value per Share | 22.39 | 21.13 | 18.44 | 18.07 | 16.82 | 15.64 | 10.75 | 11.33 | 13.12 | 13.38 | 11.93 | 12.52 | 13.17 | 11.84 | 11.10 | 10.45 | 9.36 | 8.96 | 8.50 | 6.17 | 4.98 | 3.84 | 3.41 | 1.90 | 1.28 | 0.99 | 0.88 | 0.57 | 0.40 | 0.38 | 0.40 |
| Total Shareholders' Equity | 46.8B | 44.33B | 39.47B | 39.83B | 38.17B | 36.95B | 25.42B | 26.98B | 31.97B | 31.65B | 26.27B | 27.38B | 28.89B | 25.77B | 24.28B | 22.9B | 20.37B | 19.43B | 18.37B | 13.32B | 10.69B | 8.24B | 7.32B | 6.11B | 4.87B | 3.87B | 3.22B | 1.89B | 1.28B | 1.2B | 1.07B |
| Common Stock | 11.85B | 11.41B | 11.06B | 10.71B | 10.29B | 10.17B | 7.54B | 7.35B | 9.32B | 9.11B | 4.67B | 4.54B | 4.43B | 3.85B | 3.71B | 3.51B | 0 | 2.83B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 34.68B | 32.7B | 28.1B | 28.95B | 27.67B | 26.78B | 17.87B | 19.61B | 22.53B | 22.61B | 21.53B | 22.77B | 24.41B | 21.88B | 20.52B | 19.36B | 18B | 16.7B | 15.34B | 10.58B | 8.14B | 5.8B | 4.92B | 3.65B | 2.41B | 1.91B | 1.41B | 623.55M | 424.15M | 364.55M | 253.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 262M | 218.82M | 301M | 172M | 209M | -1M | 6.28M | 26.22M | 122M | -68M | 70M | 75M | 51M | 42M | 58M | 26M | 9M | -104M | 262.26M | 72.5M | -12.81M | -9.3M | -6M | 16.75M | 23.61M | 73.23M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SCO price volatility and emissions cap
Total assets surged to $96.6B in 2026Q2 from $76.0B in 2024Q1, per reported figures, driven by a $26.1B jump in PPE, reflecting renewed investment and possibly acquisition activity.
The sequential jump in total assets from $67.6B in 2026Q1 to $96.6B in 2026Q2, with PPE increasing from $58.3B to $84.4B, suggests a major capital addition or acquisition, though the source is not disclosed. This expansion appears to be debt-funded, as total liabilities rose from $35.5B to $49.8B, while equity grew from $32.1B to $46.8B, indicating a balanced funding mix. The balance sheet is clearly strengthening in size, but the sustainability of this growth depends on commodity prices and the successful integration of any new assets.
Debt-to-equity rose to 0.37 in 2026Q2 from 0.25 in 2024Q3, per financial statements, as total debt increased to $17.1B, suggesting a strategic re-leveraging to fund growth.
After reducing debt to $10.0B in 2024Q3, total debt climbed to $19.7B by 2025Q4, then settled at $17.1B in 2026Q2, indicating a deliberate increase in leverage. The D/E ratio of 0.37 remains conservative relative to peers like Cenovus (0.54) and Ovintiv (0.67), suggesting ample debt capacity. This leverage appears strategic, likely to finance the asset expansion seen in PPE, rather than a necessity, given the company's robust cash flow generation.
PPE net of $84.4B constitutes 87% of total assets in 2026Q2, as reported in financial statements, underscoring the capital-intensive, long-life nature of oil sands assets.
The overwhelming concentration in PPE reflects CNQ's heavy investment in oil sands mining and upgrading infrastructure, which supports low-decline production. Goodwill is zero, indicating that acquisitions were asset purchases rather than stock deals, avoiding potential impairment risk. The asset mix suggests a business model that prioritizes long-term production stability over flexibility, with the massive PPE base implying high fixed costs and significant depreciation charges that will impact future earnings.
Shareholders' equity expanded to $46.8B in 2026Q2 from $39.5B in 2024Q1, per balance sheet data, with retained earnings rising to $34.7B, reflecting strong cumulative profitability.
Retained earnings grew from $28.3B in 2024Q1 to $34.7B in 2026Q2, a $6.4B increase, which is consistent with the company's policy of returning 100% of free cash flow to shareholders while still retaining a portion of earnings. The equity base is solid, with no goodwill to distort book value, and the increase in equity alongside debt suggests a balanced approach to funding growth. However, the jump in equity from $32.1B in 2026Q1 to $46.8B in 2026Q2 is unusually large, possibly reflecting a share issuance or revaluation, which warrants further investigation.
Current ratio improved to 1.00 in 2026Q2 from 0.77 in 2024Q4, per company filings, but cash of $2.6B remains modest relative to total debt of $17.1B.
The current ratio has steadily improved from 0.77 to 1.00, indicating better short-term liquidity, but it remains below the 1.57 of Cenovus and 1.39 of Suncor, suggesting a tighter working capital position. Cash increased to $2.6B in 2026Q2, a significant jump from $580.9M in 2026Q1, likely due to strong operating cash flow, but it still covers only 15% of total debt. This liquidity buffer appears adequate for operational needs, but the company may rely on credit facilities or cash flow to meet near-term obligations, given the low cash balance relative to debt.
The $26.1B sequential increase in PPE in 2026Q2, as per balance sheet data, may signal a major acquisition, but the lack of goodwill suggests a bargain purchase or asset swap.
The dramatic rise in PPE without corresponding goodwill is unusual and could indicate an acquisition of physical assets at a price below book value, or a revaluation of existing assets. This raises questions about the quality of the acquired assets and the potential for future impairment if commodity prices decline. Additionally, the increase in debt to fund this expansion, while leverage remains moderate, could strain cash flows if the assets underperform. Investors should monitor the integration and performance of these new assets, as well as any undisclosed liabilities that may accompany them.
Quick answers to the most common questions about buying CNQ stock.
As of 2025, Canadian Natural Resources Limited (CNQ) had total assets of $91.76B including $7.66B in current assets.
Canadian Natural Resources Limited (CNQ) carries total debt of $19.71B, offset by $672.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Canadian Natural Resources Limited (CNQ) has total shareholders' equity (book value) of $44.33B ($21.13 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Canadian Natural Resources Limited (CNQ) reported a current ratio of 0.95x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.